{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:20:23Z","timestamp":1769739623921,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Nano-biofarmac\u00eautica (INCT-NanoBiofar)"},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["CBB-APQ-00819-12"],"award-info":[{"award-number":["CBB-APQ-00819-12"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["CBB-APQ-01778-2014"],"award-info":[{"award-number":["CBB-APQ-01778-2014"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-482976\/2012-8"],"award-info":[{"award-number":["APQ-482976\/2012-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-488237\/2013-0"],"award-info":[{"award-number":["APQ-488237\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-467640\/2014-9"],"award-info":[{"award-number":["APQ-467640\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad-FEDER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.actatropica.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T20:01:45Z","timestamp":1448136105000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis"],"prefix":"10.1016","volume":"154","author":[{"given":"V\u00edvian Tamietti","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Pagliara","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Costa","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourena Emanuele","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Garde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella Rezende","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Mendes","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto Pereira","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Antonio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2015.11.006_bib0005","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0010","first-page":"238","article-title":"Immune response to Leishmania infection","volume":"119","author":"Awasthi","year":"2004","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0015","doi-asserted-by":"crossref","first-page":"e0003742","DOI":"10.1371\/journal.pntd.0003742","article-title":"Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis","volume":"9","author":"Baharia","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2180-14-8","article-title":"IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine","volume":"14","author":"Bhowmick","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1756-3305-4-150","article-title":"Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation","volume":"4","author":"Carri\u00f3n","year":"2011","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12026-013-8400-4","article-title":"Adverse events following immunization with vaccines containing adjuvants","volume":"56","author":"Cerpa-Cruz","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0035","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.micinf.2010.06.008","article-title":"Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB\/c mice against Leishmania chagasi and Leishmania amazonensis challenge","volume":"12","author":"Ch\u00e1vez-Fumagalli","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0040","doi-asserted-by":"crossref","first-page":"e1430","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0045","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0050","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/pr101286y","article-title":"Analysis of Leishmania chagasi by 2-D difference gel electrophoresis (2-D DIGE) and immunoproteomic: identification of novel candidate antigens for diagnostic tests and vaccine","volume":"10","author":"Costa","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0055","doi-asserted-by":"crossref","first-page":"e110014","DOI":"10.1371\/journal.pone.0110014","article-title":"Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis","volume":"9","author":"Costa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bjid.2014.10.009","article-title":"Therapy with radio-attenuated vaccine in experimental murine visceral leishmaniasis showed enhanced T cell and inducible nitric oxide synthase levels, suppressed tumor growth factor-beta production with higher expression of some signaling molecules","volume":"19","author":"Datta","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0065","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1128\/IAI.71.11.6499-6509.2003","article-title":"Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice","volume":"71","author":"Dumas","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0070","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0080","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-2478(90)90083-3","article-title":"Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from l-arginine by macrophages and hepatocytes","volume":"25","author":"Green","year":"1990","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0095","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/4000","article-title":"Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection","volume":"4","author":"Gurunathan","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0100","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0105","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2008.06.002","article-title":"Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice","volume":"10","author":"Iborra","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0110","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1128\/IAI.71.11.6562-6572.2003","article-title":"The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB\/c mice","volume":"71","author":"Iborra","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0115","doi-asserted-by":"crossref","first-page":"e1000431","DOI":"10.1371\/journal.ppat.1000431","article-title":"B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections","volume":"5","author":"Joshi","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0120","doi-asserted-by":"crossref","first-page":"e3136","DOI":"10.1371\/journal.pntd.0003136","article-title":"Visceral leishmaniasis and HIV coinfection in Latin America","volume":"8","author":"Lindoso","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0125","doi-asserted-by":"crossref","first-page":"e2148","DOI":"10.1371\/journal.pntd.0002148","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s13071-015-0964-5","article-title":"A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis","volume":"8","author":"Martins","year":"2015","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0135","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0140","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI117767","article-title":"Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis","volume":"95","author":"Murray","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0145","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0150","first-page":"273","article-title":"Leishmania donovani nucleoside hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection","volume":"5","author":"Nico","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vetpar.2008.09.015","article-title":"Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis","volume":"158","author":"Pereira","year":"2008","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0160","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.micinf.2005.10.004","article-title":"MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis","volume":"8","author":"P\u00e9rez-Jim\u00e9nez","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0165","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.vaccine.2012.12.071","article-title":"Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis","volume":"3","author":"Ram\u00edrez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0170","doi-asserted-by":"crossref","first-page":"e1003476","DOI":"10.1371\/journal.ppat.1003476","article-title":"T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine","volume":"9","author":"Schwarz","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-3024.2011.01318.x","article-title":"Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB\/c mice","volume":"33","author":"Soudi","year":"2011","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0180","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/IAI.71.8.4804-4807.2003","article-title":"Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity","volume":"71","author":"St\u00e4ger","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0185","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"St\u00e4ger","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0190","doi-asserted-by":"crossref","first-page":"iii43","DOI":"10.1136\/ard.60.90003.iii43","article-title":"Role of cytokines in the innate immune response to intracellular pathogens","volume":"60","author":"Stenger","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0195","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.imbio.2015.05.014","article-title":"Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice","volume":"220","author":"Thakur","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vetpar.2015.05.025","article-title":"Setting the proportion of CD4(+) and CD8(+) T-cells co-cultured with canine macrophages infected with Leishmania chagasi","volume":"211","author":"Viana","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","article-title":"Immunopathogenesis of infection with the visceralizing Leishmania species","volume":"38","author":"Wilson","year":"2005","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.actatropica.2015.11.006_bib0210","article-title":"Control of the leishmaniasis: report of a meeting of the WHO expert committee on the control of leishmaniases","volume":"949","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.actatropica.2015.11.006_bib0215","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.micinf.2007.05.012","article-title":"Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections","volume":"9","author":"Zanin","year":"2007","journal-title":"Microbes Infect."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15301546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15301546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T13:32:34Z","timestamp":1748698354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X15301546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":43,"alternative-id":["S0001706X15301546"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.11.006","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}